Results of a new study, which involved over 3,700 overweight and obese nondiabetic adults, reveals that combining diabetes drug liraglutide with diet and exercise was linked with significant reduction in weight as well as improvement in a number of cardiovascular risk factors including high blood pressure and high cholesterol. "If these improvements continue over time, they may result in a lower risk of heart disease," said the study's principal investigator, Carel ...
Read More
No comments:
Post a Comment